日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors

贝伐珠单抗联合替西罗莫司治疗晚期胰外神经内分泌肿瘤的II期研究

Abuzakhm, Sonia M; Sukrithan, Vineeth; Fruth, Briant; Qin, Rui; Strosberg, Jonathan; Hobday, Timothy J; Semrad, Thomas; Reidy-Lagunes, Diane; Kindler, Hedy Lee; Kim, George P; Knox, Jennifer J; Kaubisch, Andreas; Villalona-Calero, Miguel; Chen, Helen; Erlichman, Charles; Shah, Manisha H

Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies

一项针对晚期实体恶性肿瘤患者的 I 期研究,评估了口服 VEGFR 抑制剂 cediranib 与口服 MEK 抑制剂 selumetinib 联合用药的疗效。

Hubbard, Joleen M; Yin, Jun; Schenk, Erin L; Qin, Rui; Reid, Joel M; Strand, Carrie; Fiskum, Jack; Menefee, Michael; Lin, Grace; Doyle, L Austin; Ivy, Percy; Erlichman, Charles; Adjei, Alex; Haluska, Paul; Costello, Brian A

Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials

接受氟尿嘧啶联合或不联合奥沙利铂治疗的III期结肠癌患者的微卫星不稳定性:一项包含12项辅助治疗试验的ACCENT汇总分析

Cohen, Romain; Taieb, Julien; Fiskum, Jack; Yothers, Greg; Goldberg, Richard; Yoshino, Takayuki; Alberts, Steven; Allegra, Carmen; de Gramont, Aimery; Seitz, Jean-Francois; O'Connell, Michael; Haller, Daniel; Wolmark, Norman; Erlichman, Charles; Zaniboni, Alberto; Lonardi, Sara; Kerr, Rachel; Grothey, Axel; Sinicrope, Frank A; André, Thierry; Shi, Qian

Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database

早期发病的III期结肠腺癌的临床病理学和分子特征:ACCENT数据库分析

Jin, Zhaohui; Dixon, Jesse G; Fiskum, Jack M; Parekh, Hiral D; Sinicrope, Frank A; Yothers, Greg; Allegra, Carmen J; Wolmark, Norman; Haller, Daniel; Schmoll, Hans-Joachim; de Gramont, Aimery; Kerr, Rachel; Taieb, Julien; Van Cutsem, Eric; Tweleves, Christopher; O'Connell, Michael; Saltz, Leonard B; Sadahiro, Sotaro; Blanke, Charles D; Tomita, Naohiro; Seitz, Jean-Francois; Erlichman, Charles; Yoshino, Takayuki; Yamanaka, Takeharu; Marsoni, Silvia; Andre, Thierry; Mahipal, Amit; Goldberg, Richard M; George, Thomas J; Shi, Qian

An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

一项针对进展期和转移性甲状腺球蛋白抗体阴性放射性碘难治性分化型甲状腺癌的帕唑帕尼国际II期研究

Bible, Keith C; Menefee, Michael E; Lin, Chia-Chi Josh; Millward, Michael J; Maples, William J; Goh, Boon Cher; Karlin, Nina J; Kane, Madeleine A; Adkins, Douglas R; Molina, Julian R; Donehower, Ross C; Lim, Wan-Teck; Flynn, Patrick J; Richardson, Ronald L; Traynor, Anne M; Rubin, Joseph; LoRusso, Patricia M; Smallridge, Robert C; Burton, Jill K; Suman, Vera J; Kumar, Aditi; Voss, Jessie S; Rumilla, Kandalaria M; Kipp, Benjamin R; Chintakuntlawar, Ashish V; Harris, Pamela; Erlichman, Charles

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

维莫德吉联合厄洛替尼治疗转移性胰腺癌的I期临床试验

McCleary-Wheeler, Angela L; Carr, Ryan M; Palmer, Shanique R; Smyrk, Thomas C; Allred, Jacob B; Almada, Luciana L; Tolosa, Ezequiel J; Lamberti, Maria J; Marks, David L; Borad, Mitesh J; Molina, Julian R; Qi, Yingwei; Lingle, Wilma L; Grothey, Axel; Pitot, Henry C; Jatoi, Aminah; Northfelt, Donald W; Bryce, Alan H; McWilliams, Robert R; Okuno, Scott H; Haluska, Paul; Kim, George P; Colon-Otero, Gerardo; Lowe, Val J; Callstrom, Matthew R; Ma, Wen We; Bekaii-Saab, Tanios; Hung, Mien-Chie; Erlichman, Charles; Fernandez-Zapico, Martin E

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

一项针对晚期肾上腺皮质癌患者的II期临床研究,评估口服棉酚负对映体(AT-101,一种BH3模拟物)的疗效。

Xie, Hao; Yin, Jun; Shah, Manisha H; Menefee, Michael E; Bible, Keith C; Reidy-Lagunes, Diane; Kane, Madeleine A; Quinn, David I; Gandara, David R; Erlichman, Charles; Adjei, Alex A

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

纳武利尤单抗治疗复发性和转移性鼻咽癌的抗肿瘤活性:梅奥诊所二期联盟的一项国际多中心研究(NCI-9742)

Ma, Brigette B Y; Lim, Wan-Teck; Goh, Boon-Cher; Hui, Edwin P; Lo, Kwok-Wai; Pettinger, Adam; Foster, Nathan R; Riess, Jonathan W; Agulnik, Mark; Chang, Alex Y C; Chopra, Akhil; Kish, Julie A; Chung, Christine H; Adkins, Douglas R; Cullen, Kevin J; Gitlitz, Barbara J; Lim, Dean W; To, Ka-Fai; Chan, K C Allen; Lo, Y M Dennis; King, Ann D; Erlichman, Charles; Yin, Jun; Costello, Brian A; Chan, Anthony T C

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors

一项针对实体瘤患者的聚(ADP-核糖)聚合酶抑制剂维利帕尼联合每周一次拓扑替康的I期临床试验

Wahner Hendrickson, Andrea E; Menefee, Michael E; Hartmann, Lynn C; Long, Harry J; Northfelt, Donald W; Reid, Joel M; Boakye-Agyeman, Felix; Kayode, Olumide; Flatten, Karen S; Harrell, Maria I; Swisher, Elizabeth M; Poirier, Guy G; Satele, Daniel; Allred, Jake; Lensing, Janet L; Chen, Alice; Ji, Jiuping; Zang, Yiping; Erlichman, Charles; Haluska, Paul; Kaufmann, Scott H

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

首次人体I期研究:他莫昔芬代谢物Z-恩多昔芬治疗内分泌难治性转移性乳腺癌女性患者

Goetz, Matthew P; Suman, Vera J; Reid, Joel M; Northfelt, Don W; Mahr, Michael A; Ralya, Andrew T; Kuffel, Mary; Buhrow, Sarah A; Safgren, Stephanie L; McGovern, Renee M; Black, John; Dockter, Travis; Haddad, Tufia; Erlichman, Charles; Adjei, Alex A; Visscher, Dan; Chalmers, Zachary R; Frampton, Garrett; Kipp, Benjamin R; Liu, Minetta C; Hawse, John R; Doroshow, James H; Collins, Jerry M; Streicher, Howard; Ames, Matthew M; Ingle, James N